66 related articles for article (PubMed ID: 12854999)
21. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
Allen C; McDonald C; Giannini C; Peng KW; Rosales G; Russell SJ; Galanis E
J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
[TBL] [Abstract][Full Text] [Related]
22. Viruses as gene delivery vectors: application to gene function, target validation, and assay development.
Lotze MT; Kost TA
Cancer Gene Ther; 2002 Aug; 9(8):692-9. PubMed ID: 12136431
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated expression of green fluorescent protein.
de Martin R; Raidl M; Hofer E; Binder BR
Gene Ther; 1997 May; 4(5):493-5. PubMed ID: 9274728
[TBL] [Abstract][Full Text] [Related]
24. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
25. Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):183-90. PubMed ID: 9171937
[TBL] [Abstract][Full Text] [Related]
26. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
28. [Rapid and efficient expression of foreign genes in mammalian cells by baculovirus vectors].
Cheng T; Xu CY; Wang YB; Chen M; Wu T; Xie XY; Zhang J; Xia NS
Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):581-6. PubMed ID: 15969088
[TBL] [Abstract][Full Text] [Related]
29. A simple method for the rapid generation of recombinant adenovirus vectors.
Anderson RD; Haskell RE; Xia H; Roessler BJ; Davidson BL
Gene Ther; 2000 Jun; 7(12):1034-8. PubMed ID: 10871752
[TBL] [Abstract][Full Text] [Related]
30. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
Siemens DR; Crist S; Austin JC; Tartaglia J; Ratliff T
J Urol; 2003 Sep; 170(3):979-84. PubMed ID: 12913754
[TBL] [Abstract][Full Text] [Related]
31. Biophysical targeting of adenovirus vectors for gene therapy.
Silman NJ; Fooks AR
Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
[TBL] [Abstract][Full Text] [Related]
32. A suite of parallel vectors for baculovirus expression.
Pengelley SC; Chapman DC; Mark Abbott W; Lin HH; Huang W; Dalton K; Jones IM
Protein Expr Purif; 2006 Aug; 48(2):173-81. PubMed ID: 16797185
[TBL] [Abstract][Full Text] [Related]
33. [Construction and expression of replication-deficient recombinant adenovirus vector with hNET gene by adeasy-1 system].
Jia ZY; Ou XH; Wei HY; Deng HF; Huang R; Wang JR; Zhang SQ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):523-6. PubMed ID: 18798484
[TBL] [Abstract][Full Text] [Related]
34. Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins.
Whittington HA; Ashworth LJ; Hawkins RE
Gene Ther; 1998 Jun; 5(6):770-7. PubMed ID: 9747457
[TBL] [Abstract][Full Text] [Related]
35. Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors.
Di Nicola M; Siena S; Bregni M; Longoni P; Magni M; Milanesi M; Matteucci P; Mortarini R; Anichini A; Parmiani G; Drexler I; Erfle V; Sutter G; Gianni AM
Cancer Gene Ther; 1998; 5(6):350-6. PubMed ID: 9917089
[TBL] [Abstract][Full Text] [Related]
36. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
37. Using QPCR to assign infectious potencies to adenovirus based vaccines and vectors for gene therapy: toward a universal method for the facile quantitation of virus and vector potency.
Wang F; Puddy AC; Mathis BC; Montalvo AG; Louis AA; McMackin JL; Xu J; Zhang Y; Tan CY; Schofield TL; Wolf JJ; Lewis JA
Vaccine; 2005 Aug; 23(36):4500-8. PubMed ID: 16002190
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus-mediated soluble FLT-1 gene therapy for ovarian carcinoma.
Mahasreshti PJ; Navarro JG; Kataram M; Wang MH; Carey D; Siegal GP; Barnes MN; Nettelbeck DM; Alvarez RD; Hemminki A; Curiel DT
Clin Cancer Res; 2001 Jul; 7(7):2057-66. PubMed ID: 11448924
[TBL] [Abstract][Full Text] [Related]
39. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
40. Localized gene delivery using antibody tethered adenovirus from polyurethane heart valve cusps and intra-aortic implants.
Stachelek SJ; Song C; Alferiev I; Defelice S; Cui X; Connolly JM; Bianco RW; Levy RJ
Gene Ther; 2004 Jan; 11(1):15-24. PubMed ID: 14681693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
